ASTRAZENECA DL-,25 SP.ADR/ US0463531089 /
24.06.2024 9:17:34 | Изменение -0.500 | Объем сделки | Бид10:06:42 | Предложение10:06:42 | Рыночная капитализация | Дивидендная доходность | Коэффициент Цена/Доход |
---|---|---|---|---|---|---|---|
73.000EUR | -0.68% | - Оборот: - |
73.500Величина цены спроса: 250 | 74.000Величина цены предложения: 1,000 | 226.86 млрдEUR | - | - |
GlobeNewswire
10:00
OPEN Health and fusion announce partnership to deliver AI-powered healthcare communications
GlobeNewswire
10:00
TDOC INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Teladoc Health, Inc. Investors...
GlobeNewswire
10:00
INTC INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Intel Corporation Investors wi...
GlobeNewswire
9:53
Novotech Appoints Dr. Ian Braithwaite as Vice President, Global Project Management to Lead World-Cla...
GlobeNewswire
9:00
Allecra Therapeutics and Acino Sign Exclusive Licensing and Supply Agreement for Allecra’s Novel Ant...
GlobeNewswire
8:39
OKX Marketplace and Astra Nova Launch Giveaway of 500 SuperNova NFT Whitelist Spots and 50 Shards
GlobeNewswire
8:00
First gene therapy for prevalent pathologies in neurology receives FDA IND clearance - EG 427 initi...
GlobeNewswire
7:30
PolTREG’s type-1 diabetes Treg cell therapy PTG-007 demonstrates long-term safety and efficacy for u...
- Первая страница
- Назад
- 1
- 2
- 3
- 4
- Следующий
- Последняя страница